Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alex Melamud is active.

Publication


Featured researches published by Alex Melamud.


Mayo Clinic Proceedings | 2003

Ocular Ethambutol Toxicity

Alex Melamud; Gregory S. Kosmorsky; Michael S. Lee

Ethambutol is an antimicrobial agent used frequently to treat tuberculosis. The most commonly recognized toxic effect of ethambutol is optic neuropathy, which generally is considered uncommon and reversible in medical literature. We describe a 43-year-old man who developed signs and symptoms of bilateral optic neuropathy during treatment with ethambutol. This case and a review of the literature show the severe and unpredictable nature of ethambutol toxicity and its potential for irreversible vision loss despite careful ophthalmologic monitoring.


Ophthalmic Genetics | 2004

Color vision testing

Alex Melamud; Stephanie A. Hagstrom; Elias I. Traboulsi

The science of color vision testing has evolved since its inception in the late 1700s. Since then, the rudimentary technique of comparing color names has been replaced by more sophisticated methods. Commonly used tests in clinical practice today include isochromatic plates, arrangement tests, anomaloscopes, and lantern tests. Each category has unique attributes that make it suitable for a particular clinical situation. The clinician should be aware of the requirements for administering and grading each test type. Factors such as the quality of the illuminant and the size of the field of view are important elements in setting up a proper color vision laboratory. Currently, no treatment exists for congenital color vision defects. However, studies show that diagnosis of these defects early in life may help children adjust better to tasks at school and may help adults understand their limitations at work. Acquired color vision defects are often used as markers of ocular pathology in the clinical setting. Different color vision tests are appropriate for diagnosing the different categories of defects. Sometimes, a battery of tests may be appropriate. This paper is a review of the current knowledge in the field of color vision testing.


Archive | 2004

Hydroxyphenyl cross-linked macromolecular network and applications thereof

Anthony Calabro; Lee M. Akst; Daniel S. Alam; James Chan; Aniq Darr; Kiyotaka Fukamachi; Richard A. Gross; David Haynes; Keiji Kamohara; Daniel Knott; Hilel Lewis; Alex Melamud; Anthony Miniaci; Marshall Strome


Journal of Cataract and Refractive Surgery | 2006

Comatic aberration as a cause of monocular diplopia

Alex Melamud; Maria Regina Chalita; Ronald R. Krueger; Michael S. Lee


American Journal of Ophthalmology | 2006

Introducing a New Computer-based Test for the Clinical Evaluation of Color Discrimination

Alex Melamud; E. Simpson; Elias I. Traboulsi


Investigative Ophthalmology & Visual Science | 2005

A Gene for X–Linked Retinitis Pigmentosa Maps to Xq28 in a Large Ohio Family

Alex Melamud; G.–Q. Shen; L. Li; Daniel C. Chung; E. Simpson; Stephanie A. Hagstrom; Qing Kenneth Wang; Elias I. Traboulsi


Mayo Clinic Proceedings | 2004

Ocular Ethambutol Toxicity-Reply-I

Myung Soog Lee; Alex Melamud


Mayo Clinic Proceedings | 2004

Ocular Ethambutol Toxicity: In Response

Michael S. Lee; Alex Melamud


Investigative Ophthalmology & Visual Science | 2003

The Portal Color Sort Test - A New Touch Screen Computerized Test of Color Discrimination

Alex Melamud; E. Simpson; Elias I. Traboulsi

Collaboration


Dive into the Alex Melamud's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge